Evidence map›Paper›PMID 22646073›Full record

ArticleExpert opinion on drug discovery2011

Lessons from high-throughput protein crystallization screening: 10 years of practical experience.

Joseph R Luft, Edward H Snell, George T Detitta

Abstract read
In one paragraph

Article in Expert opinion on drug discovery, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Journal of applied crystallography · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Crystal structure of rofecoxib bound to human cyclooxygenase-2.Acta crystallographica. Section F, Structural biology communications · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Identifying, studying and making good use of macromolecular crystals.Acta crystallographica. Section F, Structural biology communications · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joseph R LuftHauptman-Woodward Medical Research Institute , 700 Ellicott St., Buffalo, NY 14203 , USA +1 716 898 8623 ; +1 716 898 8660 ; luft@hwi.buffalo.edu.
Edward H Snell
George T Detitta

Funding

University of Georgia ProjectU54GM094597 · NIGMS · RUTGERS, THE STATE UNIV OF N.J. · PI ROST, BURKHARD · 2010 to 2014
$36.9M
TOOLS FOR HIGH THROUGHPUT STRUCTURAL BIOLOGYU54GM074899 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI DETITTA, GEORGE T · 2005 to 2010
$16.5M
Enabling Technologies to Macromolecular CrystallizationR01GM100494 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI LUFT, JOSEPH · 2011 to 2014
$1.9M
Development of an Expert Crystallization Knowledge SystemR01GM088396 · NIGMS · HAUPTMAN-WOODWARD MEDICAL RESEARCH INST · PI SNELL, EDWARD H · 2010 to 2014
$1.7M
NIGMS NIH HHS R01 GM088396NIGMS NIH HHS R01 GM100494NIGMS NIH HHS U54 GM074899NIGMS NIH HHS U54 GM094597
6 · The paper itself

Abstract

introductionX-ray crystallography provides the majority of our structural biological knowledge at a molecular level and, in terms of pharmaceutical design, is a valuable tool to accelerate discovery. It is the premier technique in the field, but its usefulness is significantly limited by the need to grow well-diffracting crystals. It is for this reason that high-throughput crystallization has become a key technology that has matured over the past 10 years through the field of structural genomics. Areas covered : The authors describe their experiences in high-throughput crystallization screening in the context of structural genomics and the general biomedical community. They focus on the lessons learnt from the operation of a high-throughput crystallization-screening laboratory, which to date has screened over 12,500 biological macromolecules. They also describe the approaches taken to maximize the success while minimizing the effort. Through this, the authors hope that the reader will gain an insight into the efficient design of a laboratory and protocols to accomplish high-throughput crystallization on a single-, multiuser laboratory or industrial scale. Expert opinion : High-throughput crystallization screening is readily available but, despite the power of the crystallographic technique, getting crystals is still not a solved problem. High-throughput approaches can help when used skillfully; however, they still require human input in the detailed analysis and interpretation of results to be more successful.

Identifiers

PMID22646073
PMCPMC3637395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.